Introduction to the Proceedings of the Speed and Safety in Drug Discovery Symposium,hosted by the Safer Medicines Trust

FDA (2009). FDA unveils critical path opportunities list outlining blueprint to modernizing medical product development by 2010. Press release dated 16.03.09. Available at: http://www.fda.gov/bbs/topics/news/2006/NEW01336.html (Accessed 15.04.09).

FDA (2004). Challenge and Opportunity on the Critical Path to New Medical Products. Available at: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.pdf (Accessed 15.04.09). Silver Spring, MD, USA: US Department of Health and Human Services, Food and Drug Administration.

Europa (2008). Strengthening pharmacovigilance to reduce adverse effects of medicines. Press release dated 10.12.08. Available at: http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/08/782&format=HTML&aged=0&language=EN&guiLanguage=en (Accessed 15.04.09).

The National Academy of Sciences (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. Available at: http://dels.nas.edu/dels/rpt_briefs/Toxicity_Testing_final.pdf (Accessed 15.04.09). Washington, DC, USA: Board on Environmental Studies and Toxicology, The National Academies.